Can simple checks after kidney injury improve recovery?
NCT ID NCT07746063
First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time
Summary
This study follows adults who had a severe form of acute kidney injury (AKI) during a hospital stay. Researchers will use non-invasive tests to measure body composition and kidney size, and review medication plans. Participants will also be contacted by phone at 90 days and 12 months to assess their awareness of the condition, health literacy, and kidney function. The goal is to see if this comprehensive follow-up approach is linked to better patient understanding and long-term outcomes.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could point to better ways to manage acute kidney injury, reduce complications, and improve long-term outcomes for patients.
- What could go wrong
- This is an observational study, so it cannot prove cause and effect. The findings may not apply to all patients with kidney injury.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
154 people
The number who actually took part.
- Started
-
Aug 2021
- Finished
-
Sep 2022
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
In-house patients of the academic teaching hospital Braunschweig
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age: Adult patients (≥18 years) * Diagnosis: Confirmed diagnosis of Acute Kidney Injury (AKI) Stage 3, defined by one of the following: Increase in serum creatinine ≥3-fold from baseline, Serum creatinine ≥4 mg/dL with an acute rise of ≥0.5 mg/dL, Oliguria (\<0.5 mL/kg/h for \>6 hours) * Informed Consent: Willingness to provide written informed consent for participation in the study Exclusion Criteria: * Participation in another clinical trial: Participation in any other interventional or observational clinical study within the last 4 weeks prior to study enrollment * Short life expectancy: Clinically assessed life expectancy of less than 28 days by the treating physician * Inability to consent: Cognitive or language barriers that prevent informed consent or participation in telephone follow-up * Terminal illness: Active, untreated, or progressive terminal illness (e.g., advanced cancer with no curative intent) * Inability to follow up: Unavailability of contact information or inability to be reached by telephone at 90 and 365 days post-discharge
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute kidney injury are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Academic Teaching Hospital Braunschweig
Braunschweig, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Common Anti-Nausea drugs under scrutiny for kidney risk during chemo
- Heart attack delay may signal kidney risk after angioplasty
- ICU kidney injury: does the pattern predict lasting damage?
- Can a kidney ultrasound scan warn of kidney damage after heart bypass surgery?
- Two blood tests may separate real kidney harm from a false alarm
- Can watching kidney oxygen during liver surgery keep kidneys safe?